Skip to content

A preliminary study for the management mode of pregnancy with iron deficiency anemia involving hematologists

A preliminary study for the management mode of pregnancy with iron deficiency anemia involving hematologists

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000031235
Enrollment
Unknown
Registered
2020-03-25
Start date
2020-04-01
Completion date
Unknown
Last updated
2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron deficiency anemia during pregnancy

Interventions

Case series:Hematologists are involved in the management of women's health during pregnancy

Sponsors

Fuxing Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Screening of retrospective study subjects: 1. Screen the medical records of the obstetric outpatients in our hospital for filing, regular obstetric examination in the obstetric outpatients, and delivery patients in our hospital from January 2017 to December 2018; 2. Screen pregnant women's blood pressure, blood routine, premature rupture of fetal membrane, puerperal infection, and fetal growth restriction, fetal hypoxia, stillbirth, stillbirth, premature delivery, neonatal asphyxia. Screening of prospective subjects: 1. Pregnant women who can understand and abide by the research program will be registered in our hospital's obstetric outpatient department and undergo the birth inspection regularly from January 2019 to December 2020; 2. After obtaining the informed consent of the patients, the management mode of iron deficiency anemia of pregnant women participated by hematologists is used to monitor and record the blood pressure, blood routine, ferritin, premature rupture of fetal membrane, puerperal infection of the patients, and the occurrence of fetal growth restriction, fetal hypoxia, stillbirth, stillbirth, early delivery and neonatal asphyxia. Inclusion criteria: 1. Women who were registered in our hospital for 6-8 weeks of pregnancy; 2. No previous history of hypertension or high-risk pregnancy; 3. Those who can understand and abide by the research plan, agree and sign the informed consent.

Exclusion criteria

Exclusion criteria: Patients with previous blood system diseases such as iron deficiency anemia.

Design outcomes

Primary

MeasureTime frame
ferroprotein;

Countries

China

Contacts

Public ContactShang Yuxi

Fuxing Hospital Affiliated to Capital Medical University

yuxi_1988@sina.com+86 18311095788

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026